Navigation Links
CSA Medical Appoints William H. Floyd President and CEO
Date:12/2/2010

BALTIMORE, Dec. 2, 2010 /PRNewswire/ -- CSA Medical, Inc. (www.CSAmedical.com) today announced the appointment of William H. Floyd as incoming president, CEO and member of the board of directors. Floyd brings to the company more than 20 years of medical device experience, including market development roles commercializing disposables, implants, capital equipment and monitoring systems.

"We are thrilled to have Bill join the company and lead our efforts to create a world class medical device company," said Vince Owens, Chairman of the CSA Medical board of directors. "The company has made steady progress growing our customer and procedure base, and we believe that Bill has the background and experience needed to take our business to the next level of commercialization, including leading product development, clinical trials, regulatory, sales and marketing."

Prior to joining CSA Medical, Bill served as vice president of U.S. sales for Covidien following the sale of Aspect Medical Systems to Covidien in 2009. Previously, he was executive vice president of worldwide sales and marketing at Aspect Medical Systems, Inc.  Throughout a seven-year period, he managed Aspect from $19 million in revenue and a $20 million operating loss to more than $110 million in revenue and $16 million operating profit. Earlier in his career, Bill spent five years serving as vice president of marketing at Boston Scientific. In this position, he developed and executed the urology division's five year strategic plan focused on growth and diversification.  His efforts led to two acquisitions and numerous licensing and distribution agreements.  Previously, Bill held numerous senior sales and marketing positions with Johnson & Johnson (Codman & Shurtleff) and Procter and Gamble. Bill earned a bachelor's degree from the University of Vermont.

"CSA Medical's spray cryotherapy is a tremendously exciting new technology that holds promise to stop disease processes and dramatically improve the quality of life for millions of patients," said Floyd.  "I look forward to working with our team to bring the benefits of this technology to more patients across the globe as we expand our customer and procedure base."

CSA Medical, Inc develops and manufactures a proprietary therapeutic interventional treatment platform, the CryoSpray Ablation™ System, that delivers therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body. The Company is the first to harness the power of extreme cold (-196 C) liquid nitrogen therapeutic energy delivery inside the body. To learn more, please visit www.CSAmedical.com.


'/>"/>
SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
2. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
3. Draeger Teams Up with International Aid to Supply Medical Equipment for Use in Developing Countries
4. Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering
5. UBM Electronics EE Times and EDN Partner with Medical Electronics Design, MD+DI, and Others on DesignMED Event for Designers of Medical Electronics Devices
6. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
7. Varian Medical Systems to Display Medical X-Ray Tubes and PaxScan® Digital X-Ray Image Detectors at MEDICA 2010 International Trade Fair
8. Reportlinker Adds Global Medical Oxygen Systems Industry
9. China Medical Technologies Reports Second Fiscal Quarter Financial Results
10. Misonix Announces Achievement of Contract Vendor Status With Select Medical Corporation
11. Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/5/2017)... June 5, 2017 Kohll,s Pharmacy & Homecare is the ... the United States . The Raizer is a simple ... person up to an almost-standing position within a ... by one assistant and does not require any ... that a child can operate it, and lightweight ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... ... personal financial planning to families and business owners in North Central West Virginia, ... help provide services to differently abled residents in the region. , The Stepping ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... grant from the American Heart Association (AHA) to launch a Rheumatic Heart Disease ... the prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged ...
(Date:6/22/2017)... ... June 22, 2017 , ... Vighter, a premier provider ... certification for ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, South ... law has been degraded. The PSC.1 standard was created to protect fundamental freedoms ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, a premier ... private equity firm, has invested $3.35 million in the company. , “We ... Capital offers the smart money, speed to market and accountability we had been ...
Breaking Medicine News(10 mins):